Cargando…

SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II

Congenital dyserythropoietic anemia type II (CDAII) results from loss-of-function mutations in SEC23B. In contrast to humans, SEC23B-deficient mice deletion do not exhibit CDAII but die perinatally with pancreatic degeneration. Here, we demonstrate that expression of the full SEC23A protein (the SEC...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Richard, Lin, Zesen, Balbin-Cuesta, Ginette, Myers, Gregg, Friedman, Ann, Zhu, Guojing, McGee, Beth, Saunders, Thomas L., Kurita, Ryo, Nakamura, Yukio, Engel, James Douglas, Reddy, Pavan, Khoriaty, Rami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612686/
https://www.ncbi.nlm.nih.gov/pubmed/34818036
http://dx.doi.org/10.1126/sciadv.abj5293
_version_ 1784603495520796672
author King, Richard
Lin, Zesen
Balbin-Cuesta, Ginette
Myers, Gregg
Friedman, Ann
Zhu, Guojing
McGee, Beth
Saunders, Thomas L.
Kurita, Ryo
Nakamura, Yukio
Engel, James Douglas
Reddy, Pavan
Khoriaty, Rami
author_facet King, Richard
Lin, Zesen
Balbin-Cuesta, Ginette
Myers, Gregg
Friedman, Ann
Zhu, Guojing
McGee, Beth
Saunders, Thomas L.
Kurita, Ryo
Nakamura, Yukio
Engel, James Douglas
Reddy, Pavan
Khoriaty, Rami
author_sort King, Richard
collection PubMed
description Congenital dyserythropoietic anemia type II (CDAII) results from loss-of-function mutations in SEC23B. In contrast to humans, SEC23B-deficient mice deletion do not exhibit CDAII but die perinatally with pancreatic degeneration. Here, we demonstrate that expression of the full SEC23A protein (the SEC23B paralog) from the endogenous regulatory elements of Sec23b completely rescues the SEC23B-deficient mouse phenotype. Consistent with these data, while mice with erythroid-specific deletion of either Sec23a or Sec23b do not exhibit CDAII, we now show that mice with erythroid-specific deletion of all four Sec23 alleles die in mid-embryogenesis with features of CDAII and that mice with deletion of three Sec23 alleles exhibit a milder erythroid defect. To test whether the functional overlap between the SEC23 paralogs is conserved in human erythroid cells, we generated SEC23B-deficient HUDEP-2 cells. Upon differentiation, these cells exhibited features of CDAII, which were rescued by increased expression of SEC23A, suggesting a novel therapeutic strategy for CDAII.
format Online
Article
Text
id pubmed-8612686
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-86126862021-12-06 SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II King, Richard Lin, Zesen Balbin-Cuesta, Ginette Myers, Gregg Friedman, Ann Zhu, Guojing McGee, Beth Saunders, Thomas L. Kurita, Ryo Nakamura, Yukio Engel, James Douglas Reddy, Pavan Khoriaty, Rami Sci Adv Biomedicine and Life Sciences Congenital dyserythropoietic anemia type II (CDAII) results from loss-of-function mutations in SEC23B. In contrast to humans, SEC23B-deficient mice deletion do not exhibit CDAII but die perinatally with pancreatic degeneration. Here, we demonstrate that expression of the full SEC23A protein (the SEC23B paralog) from the endogenous regulatory elements of Sec23b completely rescues the SEC23B-deficient mouse phenotype. Consistent with these data, while mice with erythroid-specific deletion of either Sec23a or Sec23b do not exhibit CDAII, we now show that mice with erythroid-specific deletion of all four Sec23 alleles die in mid-embryogenesis with features of CDAII and that mice with deletion of three Sec23 alleles exhibit a milder erythroid defect. To test whether the functional overlap between the SEC23 paralogs is conserved in human erythroid cells, we generated SEC23B-deficient HUDEP-2 cells. Upon differentiation, these cells exhibited features of CDAII, which were rescued by increased expression of SEC23A, suggesting a novel therapeutic strategy for CDAII. American Association for the Advancement of Science 2021-11-24 /pmc/articles/PMC8612686/ /pubmed/34818036 http://dx.doi.org/10.1126/sciadv.abj5293 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
King, Richard
Lin, Zesen
Balbin-Cuesta, Ginette
Myers, Gregg
Friedman, Ann
Zhu, Guojing
McGee, Beth
Saunders, Thomas L.
Kurita, Ryo
Nakamura, Yukio
Engel, James Douglas
Reddy, Pavan
Khoriaty, Rami
SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
title SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
title_full SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
title_fullStr SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
title_full_unstemmed SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
title_short SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
title_sort sec23a rescues sec23b-deficient congenital dyserythropoietic anemia type ii
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612686/
https://www.ncbi.nlm.nih.gov/pubmed/34818036
http://dx.doi.org/10.1126/sciadv.abj5293
work_keys_str_mv AT kingrichard sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT linzesen sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT balbincuestaginette sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT myersgregg sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT friedmanann sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT zhuguojing sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT mcgeebeth sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT saundersthomasl sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT kuritaryo sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT nakamurayukio sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT engeljamesdouglas sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT reddypavan sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii
AT khoriatyrami sec23arescuessec23bdeficientcongenitaldyserythropoieticanemiatypeii